Cell Cryopreservation Market By Type (Cryopreservation media, Equipment), By Application (Stem cells, Oocytes cells, Sperm cells, Others), By End User (Pharmaceutical and biotechnology company, Research institute, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The cell cryopreservation market size was valued at $10.3 billion in 2022, and is projected to reach $76.6 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.. Cryopreservation involves the preservation of organelles, cells, tissues, or any other biological component by freezing them at very low temperatures (−80°C to −196°C) and suspending their cellular metabolism, which preserves the cells for an indefinite amount of time. At low temperatures, biological and chemical reactions in living cells are dramatically reduced. Thus, cryopreservation plays a vital role in maintaining the integrity and functionality of cells, which make it suitable for biological research workflows. When water within cells freezes, ice formation can cause a solute imbalance and damage the cellular structure. Thus, the proper usage of techniques and a freezing medium containing the right cryoprotectants and additives can help researchers to maximize the post-thaw viability of cells for cell culture.
The growth of the global cell cryopreservation market is majorly driven by increase in infertility among women coupled with rise in number of egg freezing cycles. According to The Society for Assisted Reproductive Technology, it was reported that the egg freezing cycle increased by 31% from 2020 to 2021 in the U.S. In addition, rise in presence of biobanks is anticipated to drive the growth of the cell cryopreservation market. Biobanking has gained prominence due to its crucial role in facilitating biomedical research, drug discovery, and personalized medicine. According to the Biobank Resource Center, as of 2023, there are 340 registered biobanks, including both Canadian and international biobanks.
Moreover, according to the Journal of Biopreservation and Biobanking, in 2022, it was reported that the BBMRI directory listed 641 biobanks from 17 countries (as of February 12, 2021). With the advancement of biobanking technologies and the establishment of larger and more comprehensive biobanks, the demand for efficient and reliable cell cryopreservation methods has grown significantly. Furthermore, increase in R&D activities in pharmaceutical and biotechnology industries, rise in government support for R&D activities, and increase in prevalence of chronic diseases such as cancer and Parkinson’s propel the growth of the market.
According to Health Resource and Service Administration, in 2023, it was reported that the donor registry contains more than 9 million potential donors in the U.S. Furthermore, as per the National Library of Medicine, in 2022, it was reported that various preclinical research activities are conducted in embryonic stem cells for the treatment of wide range of disease such as retinal diseases, Parkinson’s disease, Huntington’s disease, spinal cord injury, myocardial infarction, and type 1 diabetes. In addition, the Government of India conducted stem cell research through various departments and institutions by supporting basic as well as clinical research through national funding agencies such as the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), and Department of Science and Technology (DST).
Furthermore, according to Regulatory Affairs Professionals Society, in 2021, there were around 2,754 clinics engaged in providing stem cell therapies. Consequently, the growing demand for stem cell therapies acts as a significant driver of the cell cryopreservation market. In addition, surge in demand for personalized medicines is expected to act as a significant driver of the cell cryopreservation market. Cell-based therapies, such as immune cell-based immunotherapies and engineered cell therapies, are being explored as personalized treatment approaches. Cryopreservation enables long-term storage of patient-specific cells, including immune cells, which can be used in the development of personalized therapies.
By preserving these cells, cryopreservation ensures their availability when needed for patient-specific treatments. As the interest in personalized medicine continues to grow, the demand for cell cryopreservation methods and storage facilities increases simultaneously, thereby augmenting the growth of the global market. Furthermore, rise in infertility rates notably contributes toward the growth of the market. However, availability of alternative therapies for cell cryopreservation and high maintenance cost in storage procedure hinder the growth of the market.
The global cell cryopreservation market is segmented into type, application, end user, and region. On the basis of type, the market is bifurcated into cryopreservation media and equipment. The cryopreservation media segment is further sub segmented into ethylene glycol, dimethyl sulfoxide, glycerol, and others.. The equipment segment is subsegmented into freezers, liquid nitrogen supply tanks, and others.
Depending on application, the market is classified into stem cells, oocytes cells, sperm cells, and others. By end user, it is segregated into pharmaceutical & biotechnology company, research institute, and others. Region wise, it is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). The major companies profiled in the report include Merck Group KGaA, HiMedia Laboratories, Thermo Fisher Scientific Inc. , Eppendorf Corporate, BioLife Solutions, Inc., Lonza, Sartorius AG, Creative Biolabs, Sartorius AG, and PromoCell GmbH.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell cryopreservation market analysis from 2021 to 2031 to identify the prevailing cell cryopreservation market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cell cryopreservation market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cell cryopreservation market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Cryopreservation media
Agent
Ethylene glycol
Dimethyl sulfoxide
Glycerol
Others
Equipment
Type
Freezers
Liquid nitrogen supply tanks
Others
By Application
Stem cells
Oocytes cells
Sperm cells
Others
By End User
Pharmaceutical and biotechnology company
Research institute
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Malaysia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa,
Saudi Arabia
Rest of LAMEA
Key Market Players
BioLife Solutions, Inc.
Creative Biolabs
Danaher Corporation
Eppendorf Corporate
HiMedia Laboratories
Lonza
Merck Group KGaA
PromoCell GmbH
Sartorius AG
Thermo Fisher Scientific Inc.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Increase in number of egg freezing cycles
- 3.4.1.2. Increase in research and development activities for stem cells
- 3.4.1.3. Rise in number of biobanks and surge in demand for personalized medicines
- 3.4.2. Restraints
- 3.4.2.1. Availability of alternative therapies for cell cryopreservation
- 3.4.3. Opportunities
- 3.4.3.1. Increase in government support for research and development activities
- 3.4.3.2. Rise in focus of manufacturers on developing novel products for preserving various cells
- 3.5. COVID-19 Impact Analysis on the market
- 3.6. Patent Landscape
- CHAPTER 4: CELL CRYOPRESERVATION MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Cryopreservation media
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Cryopreservation media Cell Cryopreservation Market by Agent
- 4.3. Equipment
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Equipment Cell Cryopreservation Market by Type
- CHAPTER 5: CELL CRYOPRESERVATION MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Stem cells
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Oocytes cells
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Sperm cells
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
- CHAPTER 6: CELL CRYOPRESERVATION MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Pharmaceutical and biotechnology company
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Research institute
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: CELL CRYOPRESERVATION MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Type
- 7.2.5.1.3. Market size and forecast, by Application
- 7.2.5.1.4. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Type
- 7.2.5.2.3. Market size and forecast, by Application
- 7.2.5.2.4. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Type
- 7.2.5.3.3. Market size and forecast, by Application
- 7.2.5.3.4. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Type
- 7.3.5.1.3. Market size and forecast, by Application
- 7.3.5.1.4. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Type
- 7.3.5.2.3. Market size and forecast, by Application
- 7.3.5.2.4. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Type
- 7.3.5.3.3. Market size and forecast, by Application
- 7.3.5.3.4. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Type
- 7.3.5.4.3. Market size and forecast, by Application
- 7.3.5.4.4. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Type
- 7.3.5.5.3. Market size and forecast, by Application
- 7.3.5.5.4. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Type
- 7.3.5.6.3. Market size and forecast, by Application
- 7.3.5.6.4. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Type
- 7.4.5.1.3. Market size and forecast, by Application
- 7.4.5.1.4. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Type
- 7.4.5.2.3. Market size and forecast, by Application
- 7.4.5.2.4. Market size and forecast, by End User
- 7.4.5.3. India
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Type
- 7.4.5.3.3. Market size and forecast, by Application
- 7.4.5.3.4. Market size and forecast, by End User
- 7.4.5.4. Australia
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Type
- 7.4.5.4.3. Market size and forecast, by Application
- 7.4.5.4.4. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Type
- 7.4.5.5.3. Market size and forecast, by Application
- 7.4.5.5.4. Market size and forecast, by End User
- 7.4.5.6. Malaysia
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Type
- 7.4.5.6.3. Market size and forecast, by Application
- 7.4.5.6.4. Market size and forecast, by End User
- 7.4.5.7. Rest of Asia-Pacific
- 7.4.5.7.1. Key market trends, growth factors and opportunities
- 7.4.5.7.2. Market size and forecast, by Type
- 7.4.5.7.3. Market size and forecast, by Application
- 7.4.5.7.4. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Type
- 7.5.5.1.3. Market size and forecast, by Application
- 7.5.5.1.4. Market size and forecast, by End User
- 7.5.5.2. South Africa,
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Type
- 7.5.5.2.3. Market size and forecast, by Application
- 7.5.5.2.4. Market size and forecast, by End User
- 7.5.5.3. Saudi Arabia
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Type
- 7.5.5.3.3. Market size and forecast, by Application
- 7.5.5.3.4. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Type
- 7.5.5.4.3. Market size and forecast, by Application
- 7.5.5.4.4. Market size and forecast, by End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2022
- CHAPTER 9: COMPANY PROFILES
- 9.1. Creative Biolabs
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.2. Eppendorf Corporate
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
- 9.3. Lonza
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.4. PromoCell GmbH
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.5. Sartorius AG
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.6. BioLife Solutions, Inc.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
- 9.7. Danaher Corporation
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.7.7. Key strategic moves and developments
- 9.8. Thermo Fisher Scientific Inc.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
- 9.9. HiMedia Laboratories
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.10. Merck Group KGaA
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- LIST OF TABLES
- TABLE 01. GLOBAL CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 02. CELL CRYOPRESERVATION MARKET FOR CRYOPRESERVATION MEDIA, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. GLOBAL CRYOPRESERVATION MEDIA CELL CRYOPRESERVATION MARKET, BY AGENT, 2022-2032 ($MILLION)
- TABLE 04. CELL CRYOPRESERVATION MARKET FOR EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
- TABLE 05. GLOBAL EQUIPMENT CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 06. GLOBAL CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 07. CELL CRYOPRESERVATION MARKET FOR STEM CELLS, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. CELL CRYOPRESERVATION MARKET FOR OOCYTES CELLS, BY REGION, 2022-2032 ($MILLION)
- TABLE 09. CELL CRYOPRESERVATION MARKET FOR SPERM CELLS, BY REGION, 2022-2032 ($MILLION)
- TABLE 10. CELL CRYOPRESERVATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. GLOBAL CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 12. CELL CRYOPRESERVATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY, BY REGION, 2022-2032 ($MILLION)
- TABLE 13. CELL CRYOPRESERVATION MARKET FOR RESEARCH INSTITUTE, BY REGION, 2022-2032 ($MILLION)
- TABLE 14. CELL CRYOPRESERVATION MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 15. CELL CRYOPRESERVATION MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 16. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 17. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 18. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 19. NORTH AMERICA CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 20. U.S. CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 21. U.S. CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 22. U.S. CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 23. CANADA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 24. CANADA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 25. CANADA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 26. MEXICO CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 27. MEXICO CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 28. MEXICO CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 29. EUROPE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 30. EUROPE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 31. EUROPE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 32. EUROPE CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 33. GERMANY CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 34. GERMANY CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 35. GERMANY CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 36. FRANCE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 37. FRANCE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 38. FRANCE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 39. UK CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 40. UK CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 41. UK CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 42. ITALY CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 43. ITALY CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 44. ITALY CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 45. SPAIN CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 46. SPAIN CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 47. SPAIN CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 48. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 49. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 50. REST OF EUROPE CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 51. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 52. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 53. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 54. ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 55. JAPAN CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 56. JAPAN CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 57. JAPAN CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 58. CHINA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 59. CHINA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 60. CHINA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 61. INDIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 62. INDIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 63. INDIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 64. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 65. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 66. AUSTRALIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 67. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 68. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 69. SOUTH KOREA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 70. MALAYSIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 71. MALAYSIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 72. MALAYSIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 73. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 74. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 75. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 76. LAMEA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 77. LAMEA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 78. LAMEA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 79. LAMEA CELL CRYOPRESERVATION MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 80. BRAZIL CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 81. BRAZIL CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 82. BRAZIL CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 83. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 84. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 85. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 86. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 87. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 88. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 89. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 90. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 91. REST OF LAMEA CELL CRYOPRESERVATION MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 92. CREATIVE BIOLABS: KEY EXECUTIVES
- TABLE 93. CREATIVE BIOLABS: COMPANY SNAPSHOT
- TABLE 94. CREATIVE BIOLABS: PRODUCT SEGMENTS
- TABLE 95. CREATIVE BIOLABS: SERVICE SEGMENTS
- TABLE 96. CREATIVE BIOLABS: PRODUCT PORTFOLIO
- TABLE 97. EPPENDORF CORPORATE: KEY EXECUTIVES
- TABLE 98. EPPENDORF CORPORATE: COMPANY SNAPSHOT
- TABLE 99. EPPENDORF CORPORATE: PRODUCT SEGMENTS
- TABLE 100. EPPENDORF CORPORATE: PRODUCT PORTFOLIO
- TABLE 101. EPPENDORF CORPORATE: KEY STRATERGIES
- TABLE 102. LONZA: KEY EXECUTIVES
- TABLE 103. LONZA: COMPANY SNAPSHOT
- TABLE 104. LONZA: PRODUCT SEGMENTS
- TABLE 105. LONZA: SERVICE SEGMENTS
- TABLE 106. LONZA: PRODUCT PORTFOLIO
- TABLE 107. PROMOCELL GMBH: KEY EXECUTIVES
- TABLE 108. PROMOCELL GMBH: COMPANY SNAPSHOT
- TABLE 109. PROMOCELL GMBH: PRODUCT SEGMENTS
- TABLE 110. PROMOCELL GMBH: PRODUCT PORTFOLIO
- TABLE 111. SARTORIUS AG: KEY EXECUTIVES
- TABLE 112. SARTORIUS AG: COMPANY SNAPSHOT
- TABLE 113. SARTORIUS AG: PRODUCT SEGMENTS
- TABLE 114. SARTORIUS AG: PRODUCT PORTFOLIO
- TABLE 115. BIOLIFE SOLUTIONS, INC.: KEY EXECUTIVES
- TABLE 116. BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT
- TABLE 117. BIOLIFE SOLUTIONS, INC.: PRODUCT SEGMENTS
- TABLE 118. BIOLIFE SOLUTIONS, INC.: SERVICE SEGMENTS
- TABLE 119. BIOLIFE SOLUTIONS, INC.: PRODUCT PORTFOLIO
- TABLE 120. BIOLIFE SOLUTIONS, INC.: KEY STRATERGIES
- TABLE 121. DANAHER CORPORATION: KEY EXECUTIVES
- TABLE 122. DANAHER CORPORATION: COMPANY SNAPSHOT
- TABLE 123. DANAHER CORPORATION: PRODUCT SEGMENTS
- TABLE 124. DANAHER CORPORATION: PRODUCT PORTFOLIO
- TABLE 125. DANAHER CORPORATION: KEY STRATERGIES
- TABLE 126. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
- TABLE 127. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
- TABLE 128. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
- TABLE 129. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
- TABLE 130. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
- TABLE 131. THERMO FISHER SCIENTIFIC INC. : KEY STRATERGIES
- TABLE 132. HIMEDIA LABORATORIES: KEY EXECUTIVES
- TABLE 133. HIMEDIA LABORATORIES: COMPANY SNAPSHOT
- TABLE 134. HIMEDIA LABORATORIES: PRODUCT SEGMENTS
- TABLE 135. HIMEDIA LABORATORIES: PRODUCT PORTFOLIO
- TABLE 136. MERCK GROUP KGAA: KEY EXECUTIVES
- TABLE 137. MERCK GROUP KGAA: COMPANY SNAPSHOT
- TABLE 138. MERCK GROUP KGAA: PRODUCT SEGMENTS
- TABLE 139. MERCK GROUP KGAA: PRODUCT PORTFOLIO
- LIST OF FIGURES
- FIGURE 01. CELL CRYOPRESERVATION MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF CELL CRYOPRESERVATION MARKET, 2022-2032
- FIGURE 03. TOP INVESTMENT POCKETS IN CELL CRYOPRESERVATION MARKET (2023-2032)
- FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 05. LOW THREAT OF NEW ENTRANTS
- FIGURE 06. LOW THREAT OF SUBSTITUTES
- FIGURE 07. LOW INTENSITY OF RIVALRY
- FIGURE 08. LOW BARGAINING POWER OF BUYERS
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCELL CRYOPRESERVATION MARKET
- FIGURE 10. PATENT ANALYSIS BY COMPANY
- FIGURE 11. PATENT ANALYSIS BY COUNTRY
- FIGURE 11. CELL CRYOPRESERVATION MARKET, BY TYPE, 2022(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR CRYOPRESERVATION MEDIA, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR EQUIPMENT, BY COUNTRY 2022 AND 2032(%)
- FIGURE 14. CELL CRYOPRESERVATION MARKET, BY APPLICATION, 2022(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR STEM CELLS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR OOCYTES CELLS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR SPERM CELLS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 19. CELL CRYOPRESERVATION MARKET, BY END USER, 2022(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY, BY COUNTRY 2022 AND 2032(%)
- FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR RESEARCH INSTITUTE, BY COUNTRY 2022 AND 2032(%)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CELL CRYOPRESERVATION MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 23. CELL CRYOPRESERVATION MARKET BY REGION, 2022
- FIGURE 24. U.S. CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 25. CANADA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 26. MEXICO CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 27. GERMANY CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 28. FRANCE CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 29. UK CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 30. ITALY CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 31. SPAIN CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 32. REST OF EUROPE CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 33. JAPAN CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 34. CHINA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 35. INDIA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 36. AUSTRALIA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 37. SOUTH KOREA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 38. MALAYSIA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 39. REST OF ASIA-PACIFIC CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 40. BRAZIL CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 41. SOUTH AFRICA, CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 42. SAUDI ARABIA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 43. REST OF LAMEA CELL CRYOPRESERVATION MARKET, 2022-2032 ($MILLION)
- FIGURE 44. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 48. COMPETITIVE DASHBOARD
- FIGURE 49. COMPETITIVE HEATMAP: CELL CRYOPRESERVATION MARKET
- FIGURE 50. TOP PLAYER POSITIONING, 2022
- FIGURE 51. EPPENDORF CORPORATE: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 52. EPPENDORF CORPORATE: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 53. EPPENDORF CORPORATE: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 54. LONZA: NET SALES, 2020-2022 ($MILLION)
- FIGURE 55. LONZA: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 56. LONZA: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 57. SARTORIUS AG: NET SALES, 2020-2022 ($MILLION)
- FIGURE 58. SARTORIUS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 59. SARTORIUS AG: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 60. BIOLIFE SOLUTIONS, INC.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 61. BIOLIFE SOLUTIONS, INC.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 62. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
- FIGURE 63. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 64. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 65. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 66. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 67. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 68. MERCK GROUP KGAA: NET SALES, 2020-2022 ($MILLION)
- FIGURE 69. MERCK GROUP KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 70. MERCK GROUP KGAA: REVENUE SHARE BY REGION, 2022 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook